Loss of PTEN causes SHP2 activation, making lung cancer cells unresponsive to IFN-γ

Chia-Ling Chen, Tzu-Hui Chiang, Po-Chun Tseng, Yu-Chih Wang, Chiou Feng Lin

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)


Src homology-2 domain-containing phosphatase (SHP) 2, an oncogenic phosphatase, inhibits type II immune interferon (IFN)-γ signaling by subverting signal transducers and activators of transcription 1 tyrosine phosphorylation and activation. For cancer immunoediting, this study aimed to investigate the decrease of phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a tumor suppressor protein, leading to cellular impairment of IFN-γ signaling. In comparison with human lung adenocarcinoma A549 cells, the natural PTEN loss in another human lung adenocarcinoma line, PC14PE6/AS2 cells, presents reduced responsiveness in IFN-γ-induced IFN regulatory factor 1 activation and CD54 expression. Artificially silencing PTEN expression in A549 cells also caused cells to be unresponsive to IFN-γ without affecting IFN-γ receptor expression. IFN-γ-induced inhibition of cell proliferation and cytotoxicity were demonstrated in A549 cells but were defective in PC14PE6/AS2 cells and in PTEN-deficient A549 cells. Aberrant activation of SHP2 by ROS was specifically shown in PC14PE6/AS2 cells and PTEN-deficient A549 cells. Inhibiting ROS and SHP2 rescued cellular responses to IFN-γ-induced cytotoxicity and inhibition of cell proliferation in PC14PE6/AS2 cells. These results demonstrate that a decrease in PTEN facilitates ROS/SHP2 signaling, causing lung cancer cells to become unresponsive to IFN-γ.

Original languageEnglish
Pages (from-to)578-584
Number of pages7
JournalBiochemical and Biophysical Research Communications
Issue number3
Publication statusPublished - Oct 23 2015


  • IFN-γ
  • PTEN
  • ROS
  • SHP2
  • Signaling

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'Loss of PTEN causes SHP2 activation, making lung cancer cells unresponsive to IFN-γ'. Together they form a unique fingerprint.

Cite this